Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635 ( c ) ( 4 )

GlobeNewswire
2025.11.28 14:02
portai
I'm PortAI, I can summarize articles.

CAMBRIDGE, Mass., Nov. 28, 2025 ( GLOBE NEWSWIRE ) -- Spero Therapeutics, Inc. ( Nasdaq: SPRO ) , a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and multi-drug resistant ( MDR ) bacterial infections, today announced that on ...

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer